Abbott India's Stock Sees 3.37% Increase, Outperforms Sector and Market Trends

Jul 15 2024 01:20 PM IST
share
Share Via
Abbott India, a leading pharmaceutical company, saw a 3.37% increase in its stock price on July 15, 2024, in line with the positive trend in the market. According to MarketsMojo, the current recommendation for the stock is 'Hold', based on its recent performance and market trends. The stock has shown a positive trend and is currently trading higher than its moving averages, outperforming the Sensex in the past day and month. With its strong performance and market position, Abbott India remains a promising player in the pharmaceutical sector.
Abbott India's Stock Sees 3.37% Increase, Outperforms Sector and Market Trends
Abbott India ., a leading pharmaceutical company in the largecap industry, saw a 3.37% increase in its stock price on July 15, 2024. This rise in stock price was in line with the overall positive trend in the market, with the company's stock outperforming the sector by 1.84%. According to MarketsMOJO, a leading stock analysis and recommendation platform, the current call for Abbott India's stock is 'Hold'. This recommendation is based on the company's recent performance and market trends. In terms of price, Abbott India's stock is currently 4.59% away from its 52-week high of Rs 29628.15. However, it has shown a positive trend in the past few days, gaining after three consecutive days of fall. On July 15, the stock touched an intraday high of Rs 28360, showing a 3.32% increase. Moreover, Abbott India's stock is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in the market. In comparison to the overall market performance, Abbott India's stock has outperformed the Sensex by 3.30% in the past day and 3.29% in the past month. This shows the company's strong performance and stability in the market. Overall, Abbott India's stock has shown a positive trend and has gained the attention of investors in the largecap industry. With its consistent performance and strong market position, the company continues to be a promising player in the pharmaceutical sector.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News